PMID: 42244136

Glucagon-Like Peptide-1 Based Therapies and the Risk of Severe Gastrointestinal Motility Adverse Events: A Cohort Study.

Alkabbani Wajd, Crisafulli Salvatore, Paik Julie M, Tavakkoli Ali, Bykov Katsiaryna, Glynn Robert J, Wexler Deborah J, Patorno Elisabetta

Diabetes, obesity & metabolism · 2026

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.